Clinical Trials Browser

Phase 2 × Hepatitis B, Chronic × Clear all

NCT04294498 2025-03-26

Durvalumab for Advanced Hepatocellular Carcinoma in Patients With Active Chronic Hepatitis B Virus Infection

Phase 2 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT02289300 2020-01-13

A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients

Phase 2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis B, Chronic